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Introduction
The significant rise in consumer products and applications utilizing the antibacterial properties of silver nanoparticles (AgNPs) (e.g. food contact materials, textile, laundry detergents, dietary supplements, cosmetics, nose and eye drops) has increased the possibility of human (i.e. oral, dermal, mucosal) exposure to Ag.
1 Due to specific properties of AgNPs (i.e. small size and high reactivity) they can cross biological membranes and barriers, e.g. the placental barrier, posing risks to the growing fetus. [2] [3] [4] [5] [6] [7] [8] To obtain predictive results, the uptake and accumulation of NPs should be studied in human placental tissue since the placenta is the most species-specific organ. 9 The ex vivo dual recirculating human placental perfusion provides an excellent model to study the transfer of xenobiotics and particles at term pregnancy. In this model, human placental tissue obtained after caesarean section is cannulated from the maternal and fetal side, placed into a perfusion chamber and connected to peristaltic pumps to establish individual maternal and fetal circulations.
NPs are added to the maternal circulation and translocation to the fetal side is measured up to 4-6 h of perfusion. [10] [11] [12] In order to investigate the degree of NP accumulation in biological tissue and the influence of different characteristics of NPs on their uptake, suitable analytical methods, that release NPs from tissues and enable their detection, quantification and characterization, are required. Since the toxicity of AgNPs is related to the presence of Ag ions (Ag + ) that are released from the AgNPs by dissolution [13] [14] [15] [16] the methods should be able to selectively determine AgNPs and Ag ions as well. Frequently used methods for NPs characterization and quantification are scanning and transmission electron microscopy (SEM / TEM), light scattering (e.g. dynamic light scattering (DLS), nanoparticle tracking analysis (NTA)) or separation techniques, including field flow fractionation (FFF) and hydrodynamic chromatography (HDC). 17 The latter are most commonly coupled to inductively coupled plasma-mass spectrometry (ICP-MS) for highly sensitive and element specific detection. ICP-MS can be also combined with laser ablation (LA-ICP-MS) that images localization of NPs in tissues. 18, 19 However, none of the methods mentioned are able to simultaneously differentiate the form of a measured analyte (i.e. ionic or particulate metal) and to determine the size distribution and aggregation state of NPs. Moreover, most of them require sample preparation techniques that can change the physicochemical properties of NPs, thus introducing artefacts in their analysis.
One of the most promising methods for the determination of particle mass/number concentration and size distribution is the relatively novel analytical technique single particle ICP-MS (spICP-MS). SpICP-MS is a fast, very sensitive (ng/L concentration range) and particle number-based technique that ensures simultaneous characterization of metal in the nanoparticle and the ionic form. 20 While only simple dilution is 3 required when aqueous samples are measured by spICP-MS, NPs in biological tissues need to be released from the matrix, preferably without altering their properties. NPs in tissues are generally quantified based on the mass concentrations of the analyte measured after acid digestion of the samples, which leads to dissolution of most NPs. Alkaline solubilization, most commonly used with tetramethylammonium hydroxide (TMAH), was, on the other hand, found to be effective for releasing NPs from the tissues of Daphnia magna and Lumbriculus variegatus (AgNPs, AuNPs), 21 tissue and feces of rats (AgNPs, AuNPs), 19, 22 ground beef (AgNPs, AuNPs), 21 human hepatoma (HepG2) cells (AgNPs) 13 and primary human endothelial cells (AuNPs). 23 In a similar way, enzymatic treatment with the use of proteases has been applied for extracting NPs from the tissues of rats (AgNPs, AuNPs), 22,24 earthworms (AgNPs), 25 chicken meat (AgNPs), [26] [27] [28] [29] game meat (Pb), 30 eff yolk (AgNPs) 31 and human synovial fluid (Cr, Co). 32 Macerozyme R-10, a mixture of pectinase, cellulase and hemicellulase, has been applied for NPs in plants, e.g. shoots of tomato plants (AuNPs), 33 Lepidium sativum and Sinapis alba (PtNPs), 34 shoots of cucumber, tomato, soybean and pumpkin plants (CeO 2 NPs) 35 and roots and shoots of Arabidopsis thaliana plants (AgNPs). 36 However, sample preparation techniques that digest or solubilize the biological tissues without altering the AgNPs are still limited. A direct comparison of alkaline and enzymatic sample preparation methods followed by spICP-MS analysis has not been published yet and has not been applied for detection, characterization and quantification of NPs in human tissues. Moreover, most of the studies, where spICP-MS was used for quantification and characterization of AgNPs after their extraction from different tissue types, did not investigate the influence of potential matrix effects on NPs size calibration. 21, 26, 29 The objectives of this study were to: 1) investigate matrix-matching of calibration standards for AgNPs sizing by spICP-MS and 2) compare the two potentially suitable sample preparation methods, alkaline treatment with the use of the strong base TMAH and enzymatic treatment with the use of the stable and highly active enzyme Proteinase K, for releasing two types of AgNPs from human placental tissue. Since
AgNPs are soluble, one aspect was to distinguish between ionic and particulate Ag. The most appropriate treatment process was then applied for quantification and characterization of AgNPs accumulated in human placenta in the ex vivo human placental perfusion model.
Experimental Human placenta tissue samples
Placentas were obtained from uncomplicated term pregnancies after caesarean section at the Cantonal An 8800 Triple Quadrupole ICP-MS instrument (Agilent Technologies, California, USA) was used for single particle measurement of digested placenta tissue samples. Instrument tuning was performed prior to analysis by using a tuning solution according to the manufacturer's recommendation. Settings for the instrument are given in Table S1 . 
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A 7900 ICP-MS instrument (Agilent Technologies) was used for the measurements of Ag mass concentrations in acid digested tissue samples.
Alkaline treatment
A previously developed protocol for AuNPs in rat spleen 22 was modified to be applicable for the treatment of a larger mass of wet tissue (previously 0.020 g) by increasing the TMAH concentration from 5% to 20%.
Briefly, a mass of 0.2 g of tissue homogenate (corresponding to 0.1 g of wet tissue) was weighted and mixed with 0.3 mL of UPW and 2 mL of TMAH (25% v/v) to achieve a final concentration of 20% TMAH. After placing the samples in the sonication bath for 1 hour at room temperature (RT), they were mixed on the rotator (Ferris wheel) at RT for 23 hours. Prior to spICP-MS measurements, the samples were diluted with UPW 20-times to achieve a TMAH concentration of 1% (v/v). For further dilutions, a TMAH concentration of 1% (v/v) was maintained. All samples were prepared in duplicates.
Enzymatic treatment
A protocol originally developed for AgNPs in lean chicken meat was applied. 29 For 
Spiking experiments
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Particle analysis by spICP-MS
Data processing was performed as described previously. 32 Accurate sample flow rate (0.1 rps) was daily determined by weighing of UPW at RT as a sample. Quantification of particle size (particle diameter) was based on a calibration curve constructed from a blank (UPW) and four concentration levels of certified standard solutions of ionic Ag ranging from 0.2 to 2.0 µg/L. The isotope 107 Ag was detected using 3 ms dwell time for a total measurement time of 180 s (equivalent to 60000 data points). The ICP-MS signal intensity for each standard solution was acquired by averaging the signal intensity recorded during the 180 s measurement time. The transport efficiency was determined according to the "particle frequency" and "particle size" method. 39 For determination of the transport efficiency based on the "particle frequency" method, a reference
AuNP suspension with a known average particle diameter of 27.6 nm (based on measurements by transmission electron microscopy provided by NIST) and a gold mass concentration of 48.17 ± 0.33 µg/g (information value provided by NIST), diluted 10 7 -times with UPW was analyzed. The transport efficiency was calculated as the percentage of all Au nanoparticles detected by spICP-MS versus the theoretical (calculated) particle number in the introduced sample volume.
The transport efficiency according to the "particle size" method was determined in the following way:
First, a calibration curve that related 197 Au signal intensity (peak maximum of the intensity distribution) to particle mass was created using the reference AuNPs (particle mass 0.212 fg) in UPW. Second, a corresponding calibration curve was constructed by determining the average 197 Au signal intensity for ionic Au standards at 0, 0.2, 0.5 and 1.0 µg/L. The Au concentration was converted to Au mass by multiplication with sample flow rate and dwell time. The transport efficiency was determined by dividing the slope from the calibration curve made from the ionic Au standards by the slope from the calibration curve created from the AuNPs.
For each sample of AgNPs the 107 Ag signal intensity was recorded for 180-600 s using a dwell time of 3 ms (60000-200000 recorded data points). The recorded signal intensity data were plotted (in cps) versus number of "events", to create a signal distribution histogram using Microsoft Excel (Microsoft, WA, USA).
The signal intensity threshold above which events were considered as NPs was set to a value that corresponded to a particle diameter of 25 nm for all samples. This value resulted from the presence of ionic Ag in some of the samples (tissues samples collected after 6h of perfusion) which lead to an increase of the size limit of detection from 14 nm (determined in tissue samples collected at time 0h with no ionic Ag present) to 25 nm. The application of the same threshold for all samples ensured that a direct comparison of particle mass and number concentrations as well as median particle diameters between samples was possible. The same size threshold (i.e. 25 nm) was applied also for distinguishing particle events from the 8 instrumental background and ionic Ag signal for the AgPEG40 control particles. The dilution factors of the samples were adjusted in such a way that at least 400 particles were detected during one acquisition, to reduce the relative standard deviation of the Poisson distribution to 5%. At the same time, the number of readings/data points with particle events was limited to 20% to keep the contribution of multiple particle events to the size distribution below 10% according to Poisson statistics. All samples were prepared in duplicates.
To prevent AgNPs from sticking to the ICP-MS sample introduction system and to avoid a memory effect during ICP-MS measurements, the following washing procedure was applied after each sample:
Rinsing with a mixture of 1% (v/v) HCl, 1% (v/v) HNO 3 and 0.1% (m/v) Triton X-100 for 1 min at 0.5 rpm (1.7 mL/min), followed by rinsing with UPW for 30 s at 0.3 rpm (1 mL/min). With the applied washing procedure, a minor degree of carryover (typically between 1 and 40 NPs during 3 min of analysis) was observed. As the number of NPs in the analyzed samples was in the range of 1000 NPs (per 3 min analysis), this was evaluated as acceptable.
Results and discussion
Investigation of potential matrix effects on calibration
First, we wanted to evaluate whether ionic Ag standards (for the determination of the ICP-MS response) and
AuNPs (for determination of the transport efficiency) should be prepared in the same matrix as the digested tissue samples or whether they can be prepared in UPW. Therefore, the transport efficiency based on the particle frequency and particle size method was determined by diluting AuNP and ionic Au standards in the relevant matrices (Table 1) 
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Similar transport efficiencies (6-8%) were determined with the two methods, particle frequency and particle size method, independently of the used matrix (Table 1 ). The only exception was observed for the transport efficiency (11%) determined by the particle size method in the 1% TMAH matrix. This was related to the 54% higher ICP-MS response for ionic Au in 1% TMAH in comparison to UPW and enzyme solution.
Possibly, TMAH has a stabilizing effect for the Au ions and reduced the loss of Au ions in the sample introduction system. However, TMAH most probably does not have this effect for AuNPs and consequently, the transport efficiency (as it is based on the transport efficiency for ions) was overestimated. The ICP-MS response for ionic Ag solution in 1% TMAH and enzyme solution decreased by 19% and 56%, respectively, 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (Table 1 ). The suppression of the Ag+ sensitivity by the matrix due to the reactions with solution components relevant to environmental and biological systems was also observed in a study by Liu et al. 41 In general, a reduced ICP-MS response in a certain matrix could be explained by: 1) increased adhesion of ions to surfaces of the sample container and the sample introduction system (especially the tubings), 2) reduced nebulization efficiency (due to increased droplet size) and 3) plasma effects that lead to a reduced degree of ionization (caused by decreased plasma temperature). Explanation 1)
would mean that matrix-matching should not be applied if the matrix influences the ion adhesion but not the NP adhesion. Explanation 3) would mean that matrix-matching should be applied as the plasma effect would equally affect ions and NPs. Reduced nebulization efficiency (Explanation 2) could already be excluded based on the finding of similar transport efficiencies (Table 1) . To test which explanation is more likely, matrix matching was not applied (i.e. ICP-MS response determined for ionic Ag in UPW independent of matrix) for sizing and quantification of AgPEG40 NPs suspended in UPW, 1% TMAH and enzyme solution (30-times dilution) ( Table 2 ). As can be seen (Table 2 , Fig. 2 ), particle mass concentrations and median particle sizes obtained for AgPEG40 NPs suspended in UPW and AgPEG40 NPs spiked to 1% TMAH or enzyme solution were not significantly different (t-test). This proved that using UPW as matrix for the ionic standards was correct, as the use of the lower response determined for Ag ions in enzyme solution or TMAH solution for the calculations would have resulted in too low mass concentrations (56% or 19 lower) and too high median diameters (25% higher for enzyme matrix, i.e. around 43 nm) of the AgPEG40 NPs. This makes it likely that explanation 1 (adhesion to sample introduction system) is the reason for the decreased response, as this effects the response of the ions (standards) but not the NPs.
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Comparison of spike recoveries and AgNP size distributions after enzymatic and alkaline treatment of placenta tissues
In order to investigate how the alkaline and enzymatic treatment influences the mass concentrations and size distribution of AgNPs in placental tissue, 100 mg of tissue homogenates from a control perfusion experiment (placenta samples were collected before the start of the perfusion experiment) were spiked with AgNPs stock suspensions to achieve final Ag mass concentrations of 26. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 10 in the same way in order to make comparison between the determined mass concentrations and sizes possible.
The particle size distributions of the two types of AgNPs, AgPEG and AgCOONa, in enzymatically treated tissue and UPW were similar ( Fig. 3 and Fig. 4, left graphs) showing that enzymatic digestion did not significantly affect the particle sizes, e.g. through aggregation or dissolution. The determined median particle diameters were around 27 nm for AgPEG and 34 nm for Ag COOH, and not statistically different before and after enzymatic treatment for both particle types (Table 3) . Median diameters of AgNPs determined by spICP-MS were larger compared to the primary particle sizes observed by TEM due to relatively high size detection limit of spICP-MS (25 nm). Therefore, a relatively large fraction of the studied AgNPs that were smaller than 25 nm could not be detected by spICP-MS. Higher (total) Ag mass recoveries were obtained in enzymatically treated tissue (98 and 124%) in comparison to UPW (44 and 78%) for AgPEG and AgCOONa, respectively, which indicated a stabilizing effect of the enzymatic digest. The fraction of AgNPs > 25 nm relative to the total Ag mass concentration was not affected by the enzymatic treatment and remained 1% for AgPEG and 40% for AgCOONa as in the case of dilution in UPW. The finding of high recoveries after enzymatic treatment is in contrast to the results of one of our previous studies of gold NPs in rat spleen. 22 There, much lower particle mass recoveries (about 25%) were determined by spICPMS following enzymatic digestion. This can be attributed to the different enzymatic digestion protocol used in this study, where an approximately 10-times lower Proteinase K concentration was used (around 4 µg of Proteinase K per mg wet tissue). The present study makes use of an optimized protocol (60 µg of Proteinase K per mg of wet tissue), 29 which results in more efficient degradation of the matrix and/or better stabilization of the NPs.
After alkaline treatment, the particle size distributions of the two types of AgNPs, AgPEG and AgCOONa, showed the occurrence of larger NPs in comparison to UPW (Fig. 3 and Fig. 4 , right graphs).
The determined median particle diameters increased from around 27 nm to 36 nm for AgPEG and from 34 nm to 45 nm for Ag COOH (Table 3 ). Higher (total) Ag mass recoveries were obtained in alkaline treated tissue (118% for AgPEG and 133% for AgCOONa) in comparison to UPW (44% for AgPEG and 78% for AgCOONa). The fraction of AgNPs > 25 nm relative to the total Ag mass concentration increased from 1%
in UPW to 93% after alkaline treatment for AgPEG and from 40% to 115% for AgCOONa. These findings indicated agglomeration/aggregation of both types of AgNPs due to the alkaline treatment of the tissue. A further possible mechanism could be the formation of large AgNPs from ionic Ag that could be already present in the stock AgNP suspensions and/or could originate from AgNPs dissolution during the alkaline treatment.
Insert Figure 3 and Figure 4 about here
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In the only published study, that used TMAH solubilization followed by spICP-MS analysis for releasing of AgNPs from biological matrices so far, no significant (> 5 nm) change of the size distribution of 100 nm AgNPs with PVP coating was observed after alkaline treatment of ground beef (Ag spiking concentration of 0.019 mg/kg wet weight). 21 A "nearly identical" size distribution was described for a mixture of 60 nm and 100 nm AgNPs. The presented histograms indicated a slight shift of the size distribution to larger size values after alkaline treatment.
Insert Table 3 Table 4 . As it can be seen, a significant number of particles (8, 383 ) was formed after alkaline treatment of the spiked placental tissue sample with a median particle size of 33 nm, while 50 particles with 29 nm median size were detected for the same concentration of ionic Ag in 1% TMAH. Ag precipitation during alkaline treatment apparently occurs due to the components present in the tissue or perfusion medium (e.g. chlorides, sulfides) and not only because of the use of 1% TMAH.
Gomes et al. 42 observed Ag particle formation in alkaline conditions in the presence of alkoxides as reducing agents, formed from any molecule containing a hydroxyl (OH) group. In our case, alkaline TMAH and the presence of the tissue that contains proteins with -OH groups might create an ideal environment for the formation of particles. Enzymatic treatment on the other hand did not cause significant formation of particles, neither in treated placental tissue nor in enzymatic solution alone. 2 ± 1 and 35 ± 5 particles were detected in enzymatically and alkaline treated control tissue samples, respectively, probably due to the carryover from previous measurements.
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From the data presented in Table 4 it can be concluded that Ag precipitation contributed, at least to a certain extent, to the above described results for AgPEG and AgCOONa in alkaline treated tissue. It was also demonstrated that TMAH itself does not lead to a significant particle formation when there is no tissue present. In the study by Gray et al., 21 no particle formation from ionic Ag was observed. The spiking 12 concentration for ionic Ag were 50-times lower (0.04 mg Ag + /kg tissue ) compared to the concentration used in our study (2 mg Ag+/kg tissue ). The ratio between TMAH volume and tissue mass of both studies was similar.
The method described by Gray et al. 21 adds 10 mL of TMAH to 0.5 g tissue, resulting in a final TMAH concentration of 20%. We use 0.1 g tissue (in 0.2 g tissue homogenate) and add 2 mL of TMAH and 0.3 mL UPW, resulting in a final TMAH concentration of 20% as well. Further work is required to understand the observed differences of the two studies.
Quantification and characterization of AgNPs accumulated in human placenta in the ex vivo human placental perfusion model
Enzymatic treatment of the placental tissue followed by spICP-MS analysis was proven to be effective for characterization and quantification of AgCOONa and AgPEG NPs, which were spiked to placental tissue samples. However, accumulation of NPs under real exposure scenarios involves many dynamic interactions between NPs, matrix and biological processes of the target organism. 25 Therefore, for testing if the same procedure was capable of extracting AgNPs accumulated under a realistic exposure scenario, placental tissues from human ex vivo placenta perfusion experiments were investigated.
The median sizes and mass fractions of AgNPs > 25 nm for AgPEG NPs and AgCOONa NPs accumulated in the placental tissue after 6 h of perfusion (data not shown) as well as size distributions (Fig.   S1 , ESI) were determined by spICP-MS and were comparable to the values obtained for the suspensions in UPW and in the spiking experiments (Table 3 ). This indicates that either no dissolution of the AgNPs occurred during their accumulation in human placental tissue or that spICP-MS cannot provide information about the agglomeration state of the NPs in the tissue as it can be altered by the high sample dilution. (Table 5) .
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There was no significant difference (t-test, p > 0.01) between the Ag concentrations determined after enzymatic treatment (spICPMS) and acid digestion (conventional ICPMS) in the tissue samples, suggesting that enzymatic treatment of the placental tissue is capable of extracting all AgNPs from tissues, similar to a more traditional acid digestion.
Conclusions
The results showed that enzymatic treatment with Protease K is a suitable method for characterization of different types of AgNPs in placental tissue. Alkaline treatment followed by sp-ICP-MS analysis could not 13 be used for extracting AgNPs from the placental tissue samples because it changes the state of AgNPs, most probably by Ag + precipitation and/or AgNP aggregation. Our work further showed that matrix matching of ionic Ag standards cannot be applied in the case of enzymatic digestion and alkaline solubilization probably due to increased adhesion of ions in the sample introduction system in these matrices. In tissue spiking experiments, the same size distribution as for the pristine AgNPs were determined although no matrix matching was performed. The results show that matrix matching can lead to inaccurate results and that UPW can be a suitable diluent.
The optimized analytical method with the use of enzymatic digestion coupled to spICP-MS was successfully applied for quantification and sizing of AgPEG and AgCOONa NPs accumulated in placenta during ex vivo human perfusion experiment. Ag mass recovered from placental tissue using enzymatic digestion coupled to spICPMS analysis was comparable to the total Ag mass recovered using microwaveassisted digestion. Besides quantifying AgNPs accumulated in placenta, the method also provides additional information on characterization of AgNPs (e.g. size distribution, ionic/particulate form of Ag) that can significantly contribute to the interpretation of toxicological data generated during human placenta perfusion experiments.
Despite many advantages of spICP-MS, the technique still has several limitations. It is limited in terms of relatively high size detection limits. A relatively large fraction of the studied AgNPs could not be detected by spICP-MS as the NPs were in the size range of 2-15 nm. Moreover, the required high sample dilution of the NPs suspensions and sample preparation in the case of (semi)solid matrices most likely affects agglomeration/aggregation and/or dissolution state of the NPs. 43 Also, for accurate determination of NP size by spICP-MS, the shape, density and chemical composition of the analyzed NPs need to be known. In addition, standard reference materials of NPs with very carefully determined properties are needed to standardize spICP-MS technique, which includes the assessment of the reliability and variability of size and concentration determinations.
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